Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β

Journal of Cell Science

Volumn 118, Issue 10, 2005, Pages 2143-2153

  Stuelten, Christina H ^a   DaCosta Byfield, Stacey ^a   Arany, Praveen R ^a   Karpova, Tatiana S ^a   Stetler Stevenson, William G ^a   Roberts, Anita B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Coculture; MMP 9; TGF ; TNF

Indexed keywords

GELATINASE B; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; RAS PROTEIN; SMAD PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CELL FUNCTION; CELL INTERACTION; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; EMBRYO; FIBROBLAST; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STROMA CELL; ZYMOGRAPHY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM TRANSPLANTATION; PROTEIN KINASES; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 21044440756     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02334     Document Type: Article

References (66)

1. Argast, G. M., Campbell, J. S., Brooling, J. T. and Fausto, N. (2004). Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J. Biol. Chem. 279, 34530-34536.
2. Baker, E. A., Stephenson, T. J., Reed, M. W. and Brown, N. J. (2002). Expression of proteinases and inhibitors in human breast cancer progression and survival. Mol. Pathol. 55, 300-304.
3. Behrens, P., Rothe, M., Wellmann, A., Krischler, J. and Wernert, N. (2001). The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J. Pathol. 194, 43-50.
4. Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G. and Moses, H. L. (2004). TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848-851.
5. Bissell, M. J. and Radisky, D. (2001). Putting tumours in context. Natl. Rev. Cancer 1, 46-54.
6. Brown, P. D., Levy, A. T., Margulies, I. M., Liotta, L. A. and Stetler-Stevenson, W. G. (1990). Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 50, 6184-6191.
7. Davies, B., Miles, D. W., Happerfield, L. C., Naylor, M. S., Bobrow, L. G., Rubens, R. D. and Balkwill, F. R. (1993). Activity of type IV collagenases in benign and malignant breast disease. Brit. J. Cancer 67, 1126-1131.
8. Dawson, P. J., Wolman, S. R., Tait, L., Heppner, G. H. and Miller, F. R. (1996). MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am. J. Pathol. 148, 313-319.
9. Dong-Le Bourhis, X., Berthois, Y., Millot, G., Degeorges, A., Sylvi, M., Martin, P. M. and Calvo, F. (1997). Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int. J. Cancer 71, 42-48.
10. Elenbaas, B. and Weinberg, R. A. (2001). Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264, 169-184.
11. Fedarko, N. S., Jain, A., Karadag, A. and Fisher, L. W. (2004). Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J. 18, 734-736.
12. Flanders, K. C., Sullivan, C. D., Fujii, M., Sowers, A., Anzano, M. A., Arabshahi, A., Major, C., Deng, C., Russo, A., Mitchell, J. B. et al. (2002). Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am. J. Pathol. 160, 1057-1068.
13. Fridman, R., Fuerst, T. R., Bird, R. E., Hoyhtya, M., Oelkuct, M., Kraus, S., Komarek, D., Liotta, L. A., Berman, M. L. and Stetler-Stevenson, W. G. (1992). Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J. Biol. Chem. 267, 15398-15405.
14. Fridman, R., Bird, R. E., Hoyhtya, M., Oelkuct, M., Komarek, D., Liang, C. M., Berman, M. L., Liotta, L. A., Stetler-Stevenson, W. G. and Fuerst, T. R. (1993). Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme. Biochem. J. 289 (Pt 2), 411-416.
15. Giannelli, G., Fransvea, E., Marinosci, F., Bergamini, C., Daniele, A., Colucci, S., Paradiso, A., Quaranta, M. and Antonaci, S. (2002). Gelatinase levels in male and female breast cancer. Biochem. Biophys. Res. Commun. 292, 161-166.
16. Hagemann, T., Robinson, S. C., Schulz, M., Trumper, L., Balkwill, F. R. and Binder, C. (2004). Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-(R) dependent upregulation of matrix metalloproteases. Carcinogenesis 25, 1543-1549.
17. Hanemaaijer, R., Verheijen, J. H., Maguire, T. M., Visser, H., Toet, K., McDermott, E., O'Higgins, N. and Duffy, M. J. (2000). Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int. J. Cancer 86, 204-207.
18. Heldin, C. H., Miyazono, K. and ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
19. Heppner, G. H., Miller, F. R. and Shekhar, P, M. (2000). Nontransgenic models of breast cancer. Breast Cancer Res. 2, 331-334.
20. Idriss, H. T. and Naismith, J. H. (2000). TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc. Res. Tech. 50, 184-195.
21. Jones, C. B., Sane, D. C. and Herrington, D. M. (2003a). Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc. Res. 59, 812-823.
22. Jones, J. L., Shaw, J. A., Pringle, J. H. and Walker, R. A. (2003b). Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J. Pathol. 201, 562-572.
23. Kuperwasser, C., Chavarria, T., Wu, M., Magrane, G., Gray, J. W., Carey, L., Richardson, A. and Weinberg, R. A. (2004). Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. USA 101, 4966-4971.
24. Laping, N. J., Grygielko, E., Mathur, A., Butter, S., Bomberger, J., Tweed, C., Martin, W., Fornwald, J., Lehr, R., Harling, J. et al. (2002). Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol. Pharmacol. 62, 58-64.
25. Lewis, M. P., Lygoe, K. A., Nystrom, M. L., Anderson, W. P., Speight, P. M., Marshall, J. F. and Thomas, G. J. (2004). Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Brit. J. Cancer 90, 822-832.
26. Liotta, L. A. and Stetler-Stevenson, W. G. (1990). Metalloproteinases and cancer invasion. Semin. Cancer Biol. 1, 99-106.
27. Liotta, L. A. and Kohn, E. C. (2001). The microenvironment of the tumour-host interface. Nature 411, 375-379.
28. Locksley, R. M., Killeen, N. and Lenardo, M. J. (2001). The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501.
29. Lynch, C. C. and Matrisian, L. M. (2002). Matrix metalloproteinases in tumor-host cell communication. Differentiation 70, 561-573.
30. Marchetti, L., Klein, M., Schlett, K., Pfizenmaier, K. and Eisel, U. L. (2004). TNF mediated neuroprotection against glutamate induced excitotoxicity is enhanced by NMDA receptor activation: Essential role of a TNF receptor 2 mediated, PI3 kinase dependent NF-kB pathway. J. Biol. Chem. 279, 32869-32881.
31. Massague, J. (2000). How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1, 169-178.
32. Menashi, S., Serova, M., Ma, L., Vignot, S., Mourah, S. and Calvo, F. (2003). Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells. Cancer Res. 63, 7575-7580.
33. Miller, F. R., Santner, S. J., Tait, L. and Dawson, P. J. (2000). MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J. Natl. Cancer Inst. 92, 1185-1186.
34. Monteagudo, C., Merino, M. J., San Juan, J., Liotta, L. A. and Stetler-Stevenson, W. G. (1990). Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am. J. Pathol. 136, 585-592.
35. Mook, O. R., van Overbeek, C., Ackema, E. G., van Maldegem, F. and Frederiks, W. M. (2003). In situ localization of gelatinolytic activity in the extracellular matrix of metastases of colon cancer in rat liver using quenched fluorogenic DQ-gelatin. J. Histochem. Cytochem. 51, 821-829.
36. Muraoka, R. S., Koh, Y., Roebuck, L. R., Sanders, M. E., Brantley-Sieders, D., Gorska, A. E., Moses, H. L. and Arteaga, C. L. (2003). Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1. Mol. Cell Biol. 23, 8691-8703.
37. Nabeshima, K., Inoue, T., Shimao, Y. and Sameshima, T. (2002). Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol. Int. 52, 255-264.
38. Nielsen, B. S., Sehested, M., Kjeldsen, L., Borregaard, N., Rygaard, J. and Dano, K. (1997). Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer. Lab. Invest. 77, 345-355.
39. Noel, A. and Foidart, J. M. (1998). The role of stroma in breast carcinoma growth in vivo. J. Mammary Gland. Biol. 3, 215-225.
40. Olumi, A. F., Grossfeld, G. D., Hayward, S. W., Carroll, P. R., Tlsty, T. D. and Cunha, G. R. (1999). Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002-5011.
41. Park, Y. H., Ryu, H. S., Choi, D. S., Chang, K. H., Park, D. W. and Min, C. K. (2003). Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture. Int. J. Gynecol. Cancer 13, 53-60.
42. Petersen, O. W., Nielsen, H. L., Gudjonsson, T., Villadsen, R., Rank, F., Niebuhr, E., Bissell, M. J. and Ronnov-Jessen, L. (2003). Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am. J. Pathol. 162, 391-402.
43. Radisky, D. C. and Bissell, M. J. (2004). Cancer. Respect thy neighbor! Science 303, 775-777.
44. Rha, S. Y., Kim, J. H., Roh, J. K., Lee, K. S., Min, J. S., Kim, B. S. and Chung, H. C. (1997). Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression. Breast Cancer Res. Tr. 43, 175-181.
45. Roberts, A. B. and Wakefield, L. M. (2003). The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. USA 100, 8621-8623.
46. Rosen, E. M., Joseph, A., Jin, L., Rockwell, S., Elias, J. A., Knesel, J., Wines, J., McClellan, J., Kluger, M. J., Goldberg, I. D. et al. (1994). Regulation of scatter factor production via a soluble inducing factor. J. Cell Biol. 127, 225-234.
47. Rundhaug, J. E., Park, J., Pavone, A., Opdenakker, G. and Fischer, S. M. (1997). Opposite effect of stable transfection of bioactive transforming growth factor-beta 1 (TGF beta 1) versus exogenous TGF beta 1 treatment on expression of 92-kDa type IV collagenase in mouse skin squamous cell carcinoma CH72 cells. Mol. Carcinogen. 19, 122-136.
48. Saad, S., Bendall, L. J., James, A., Gottlieb, D. J. and Bradstock, K. F. (2000). Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts. Breast Cancer Res. Tr. 63, 105-115.
49. Saad, S., Gottlieb, D. J., Bradstock, K. F., Overall, C. M. and Bendall, L. J. (2002). Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res. 62, 283-289.
50. Santner, S. J., Dawson, P. J., Tait, L., Soule, H. D., Eliason, J., Mohamed, A. N., Wolman, S. R., Heppner, G. H. and Miller, F. R. (2001). Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res. Tr. 65, 101-10.
51. Scorilas, A., Karameris, A., Arnogiannaki, N., Ardavanis, A., Bassilopoulos, P., Trangas, T. and Talieri, M. (2001). Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Brit. J. Cancer 84, 1488-1496.
52. Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J. and Massague, J. (2003). Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. USA 100, 8430-8435.
53. Singer, C. F., Kronsteiner, N., Marton, E., Kubista, M., Cullen, K. J., Hirtenlehner, K., Seifert, M. and Kubista, E. (2002). MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res. Tr. 72, 69-77.
54. Sizemore, N., Agarwal, A., Das, K., Lerner, N., Sulak, M., Rani, S., Ransohoff, R., Shultz, D. and Stark, G. R. (2004). Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genes. Proc. Natl. Acad. Sci. USA 101, 7994-7998.
55. Sternlicht, M. D. and Werb, Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516.
56. Stetler-Stevenson, W. G. (1990). Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 9, 289-303.
57. Szlosarek, P. W. and Balkwill, F. R. (2003). Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol. 4, 565-573.
58. Tang, B., Vu, M., Booker, T., Santner, S. J., Miller, F. R., Anver, M. R. and Wakefield, L. M. (2003). TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J. Clin. Invest 112, 1116-1124.
59. Tian, F., DaCosta, B. S., Parks, W. T., Yoo, S., Felici, A., Tang, B., Piek, E., Wakefield, L. M. and Roberts, A. B. (2003). Reduction in smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res. 63, 8284-8292.
60. Uchiyama-Tanaka, Y., Matsubara, H., Mori, Y., Kosaki, A., Kishimoto, N., Amano, K., Higashiyama, S. and Iwasaka, T. (2002). Involvement of HB3-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells. Kidney Int. 62, 799-808.
61. Wakefield, L. M. and Roberts, A. B. (2002). TGF-beta signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22-29.
62. Wang, T. N., Albo, D. and Tuszynski, G. P. (2002). Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production. Surgery 132, 220-225.
63. Watabe, T., Yoshida, K., Shindoh, M., Kaya, M., Fujikawa, K., Sato, H., Seiki, M., Ishii, S. and Fujinaga, K. (1998). The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int. J. Cancer 77, 128-137.
64. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F. and Massague, J. (1994). Mechanism of activation of the TGF-beta receptor. Nature 370, 341-347.
65. Xu, J., Rodriguez, D., Petitclerc, E., Kim, J. J., Hangai, M., Moon, Y. S., Davis, G. E., Brooks, P. C. and Yuen, S. M. (2001). Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J. Cell Biol. 154, 1069-1079.
66. Yang, W. L., Godwin, A. K. and Xu, X. X. (2004). Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk. Cancer Res. 64, 1534-1540.